Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
作者信息
Lyman Gary H, Moses Harold L
机构信息
From the Fred Hutchinson Cancer Research Center and the University of Washington - both in Seattle (G.H.L.); the Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, National Academies of Sciences, Engineering, and Medicine, Washington, DC (G.H.L., H.L.M.); and Vanderbilt University, Nashville (H.L.M.).
出版信息
N Engl J Med. 2016 Jul 7;375(1):4-6. doi: 10.1056/NEJMp1604033. Epub 2016 Jun 1.
PMID:27353537
Abstract
摘要
Zotero 插件